The international spotlight has brightly shone on early detection, thus making the mammography market continue to grow steadily. Increasing awareness campaigns, better screening programs, and attractive reimbursement policies continued pushing the demand for mammographic systems.
A market has been developing from USD 2,279.1 Million in 2025 to 5,700.1 Million USD by 2035, thereby scoring up a compound annual growth rate (CAGR) of about 9.6% during the forecast period.
Governments and health organizations are now continuing to develop national screening programs that will address early detection of breast cancers. With the increase in the incidence rates of breast cancers, particularly among women aged 40 years and above, there has been a complementary upward trend in demand for further advancement in mammography.
High definition 3D digital breast tomosynthesis, artificial intelligence-enabled imaging, but mostly portable mammography will redefine early diagnostic capability with clearer, more accurate images.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 2,279.1 Million |
| Market Value (2035F) | USD 5,700.1 Million |
| CAGR (2025 to 2035) | 9.6% |
Explore FMI!
Book a free demo
With effective healthcare infrastructure coupled with heightened awareness of breast cancer screening and sustained government-led campaigns, North America provides the largest mammography market on a global scale. The USA is still the biggest contributor flush with the advanced diagnostic centres existing and the never-ending upgrades in technology in mammography.
Rising preventive health expenditure and improved reimbursement policies are other factors supporting market growth in this region.
The strong uptake of mammography systems across Europe - notably in the UK, Germany, and France follows closely behind. The role that government-sponsored population-based screening programs have played in increasing the markets demand has been significant. AI-assisted imaging and mobile screening units have further widened access for the rural and underserved.
Rapid growth is on the cards for the mammography markets in the Asia Pacific region because of the increasing incidence of breast cancer, heightened investments in healthcare facilities, and promotional campaigns launched by public and private organizations.
The countries China, India, Japan, and South Korea have invested highly in upgrading their diagnostic infrastructures, creating market opportunities during the forecast period for the players in the markets.
High Equipment and Maintenance Costs
Mammography is an expensive business because the starting costs of purchasing and maintaining equipment are exorbitant. Initial costs for both digital and 3D mammography systems deter small-scale diagnostic centres from making these available. Most small diagnostic centres operate in low- and middle-income economies.
This equipment requires trained personnel who have the capability of interpreting images correctly and operating the system efficiently, thereby making operations costlier to manage. The main result of all these factors is limited adoption of mammography systems in countries with low economic viability.
Technological Advancements and AI Integration
Integration of cutting-edge imaging technologies into artificial intelligence, for instance, is expected to create tremendous space for the mammography systems market. It enables diagnostic accuracy and correction of false positives and false negatives while supporting radiologists across the areas of early cancer assessment by connecting portable and mobile mammography units to far-off regions and rural populations, enhancing the screening services that travel much farther afield. Thus, innovations are destined to realize improvements in detection efficiency globally and stimulate growth in the overall market.
Between the years 2020 and 2024, the mammography market was digitally consolidating itself with the transition from analog systems to digital and 3D imaging, coupled with the heightening of awareness campaigns regarding breast cancer. From 2025 to 2035, according to expectations, the market will be a whole AI-enabled diagnostic ecosystem with personalized screening protocols and an increase in cloud-based storage of images for remote diagnostic applications.
There will further be advancement to personalized health care and risk-based screening strategies in future growth. In practice, health care providers will deploy their patients' profiles in AI algorithms to determine the frequency of screening, which is expected to improve early detection and ultimately patient outcomes. In addition, portable mammography systems and mobile screening vans would give access to the cities to diagnostic care in the underserved populations, particularly in developing regions.
Market Shifts: 2020 to 2024 vs. 2025 to 2035
| Key Dimensions | 2020 to 2024 |
|---|---|
| Imaging Technology | Transition from analog to digital systems |
| Key Drivers | Awareness campaigns, national screening programs |
| Market Expansion | Developed markets |
| Equipment Type | Standard digital mammography |
| Patient Focus | General population screening |
| Diagnostic Infrastructure | Hospital and diagnostic center installations |
| Clinical Workflow | Radiologist-dependent diagnosis |
| Key Dimensions | 2025 to 2035 |
|---|---|
| Imaging Technology | Widespread adoption of 3D tomosynthesis and AI tools |
| Key Drivers | Risk-based screening, AI-driven diagnostics |
| Market Expansion | Rapid growth in Asia-Pacific and Latin America |
| Equipment Type | Portable, mobile, and AI-enabled systems |
| Patient Focus | Personalized and risk-stratified screening |
| Diagnostic Infrastructure | Expansion into rural and underserved areas |
| Clinical Workflow | Augmented diagnosis with AI and remote consultation |
With the growing campaign for early detection of breast cancer among the population and rigorous government programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), the mammography market in the United States witnesses rapid growth. The country benefits from widespread screening programs and fast adoption master-level advanced imaging technologies with comprehensive reimbursement regimes.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 9.9% |
The growth of the mammography market in the UK is being driven by government-endorsed screening programs and greater awareness towards breast health. The National Health Service (NHS) provides an organized breast screening service that enhances early diagnostic efforts and continuity of monitoring.
Improvements in imaging systems coupled with training for radiologists have helped grow the diagnostic power in the country considerably. Increasing breast cancer cases, public awareness, and advanced innovations in 3D imaging continue to spur phenomenal market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 9.2% |
Mammography in the European Union is spawning consistent growth due to synergistic policies on cancer screening and the usage of digital imaging technologies. Germany, France, and Italy lead in deploying high-resolution 2D and 3D mammography units.
The European Commission is promoting breast cancer screening, and regulatory incentives further facilitate the modernization of equipment. Inter-country collaborative clinical research and AI integration are being promoted for enhancing diagnostic accuracy and encouraging early intervention strategies.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union | 9.5% |
Mammography in Japan is getting better almost to the end-of-the-era government emphasis on early discovery and public awareness about the diseases. The Ministry of Health, Labour, and Welfare is often seen conducting screening campaigns and supporting mobile mammography services, especially in the countryside.
An increase in the elderly population and incidence of breast cancer in the country has created a higher demand for advanced diagnostic systems. Small, compact devices are getting domestic manufacturers and global leaders pushing development. These devices are AI-embedded models aimed at both urban clinics and regional hospitals.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 8.7% |
The mammography market in South Korea is growing very rapidly due to the increased awareness of breast cancers and the improvement of the health systems in the country. Health insurance has made regular screenings easy as they are now covered under national health insurance schemes.
Health promotion policies are for early detection from the government. Emerging Next-Gen mammography technologies are being adopted using some very strong digital health capabilities and a highly advanced medical device manufacturing ecosystem. The rising appeal of low-radiation diagnostics is rapidly increasing market momentum.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 9.5% |
Breast Tomosynthesis Steals the Spotlight as the Future of Mammography
| Product Type | Market Share |
|---|---|
| Breast Tomosynthesis | 53.6% |
Breast tomosynthesis is anticipated to be the forte of the mammography market in the coming years, probably by the year 2025, with nearly 53.6% of the market share. Advanced imaging is rapidly becoming the visit due to its scope in providing threedimensional imaging of breast tissues.
Tomosynthesis is clearing one of the most critical limitations of 2D mammography-tissue overlap which may obscure tumours or create false-positive results. The acquisition of multiple X-ray images from various angles and the reconstruction of these images into a layered 3D view are the essential working principles that define tomosynthesis.
This technology has its stars in breast tomosynthesis, which has been adopted in hospitals, diagnostic centres, and screening programs globally, as it appears to improve its accuracy in identifying cases of invasive breast cancers of women with dense breast tissue. In addition, it also reduces the need for unnecessary biopsy and follow-up imaging-an important factor for patients and serves to reduce costs for the healthcare system, hence fostering uptake of the technology.
Ongoing Innovations in this field involve AI-integration within diagnostic instruments, dose-reduction technologies in addition to higher quality images. Advocacy early detection of breast cancer continues to strengthen tomosynthesis globally-in both advanced countries or emerging markets. Combined, these variables assure breast tomosynthesis as an ever-increasing impending flagship product types within the ambit of mammography in the near future.
Digital Mammography Powers the Shift toward Smarter Breast Imaging
| Technology Type | Market Share |
|---|---|
| Digital | 46.9% |
From the forecasts, digital mammography is poised to dominate the technology segment of the mammography market by 2025, accounting for almost about 46.9% of the segment. Transformations have already started from analog to digital systems that have revolutionized the field of breast imaging, allowing for fast image acquisition, better resolution, and integration of images into electronic health records (EHRs) systems.
The advent of digital technology has numerous advantages over analog, such as reducing the amount of radiation exposure to patients and the instant availability of images for analysis. This fast workflow increases the patient turnover in crowded screening centres and decreases the time to diagnosis. Additionally, the digital domain supports state-of-the-art AI-assisted image processing and CAD systems, which have come to the forefront to aid radiologists to early detection of abnormalities.
Digital mammography will execute its expansion based on breast cancer screening awareness, governmental and NGO efforts that promote access in underserved countries, and healthcare providers that upgrade their imaging infrastructure. Though 3D tomosynthesis has witnessed a fast growth, 2D digital mammography continues to be an important element for many clinical applications, maintaining its steady status and standing in the panorama of mammography.
Noble projections for the mammography market are vividly, notwithstanding with the right nuance, being ushered in largely due to increased breast cancer incidence, awareness about early detection, solutions regarding advancing in mammography technologies, including 3D tomosynthesis and AI-assisted imaging, from 2025 to 2035.
Healthcare facilities are, hence, adopting imaging solutions that are more precise and faster for better diagnostic and patient outcomes. Furthermore, government initiatives relating to breast cancer screening programs and increasing healthcare infrastructure in developing markets are running an impetus to market growth. Innovations are also increasing accessibility and efficiency, such as portable and automated mammography systems.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| GE Healthcare | 22-26% |
| Hologic, Inc. | 18-22% |
| Siemens Healthineers | 15-19% |
| Fujifilm Holdings Corporation | 10-13% |
| Other Companies (combined) | 28-32% |
| Company Name | Key Offerings/Activities |
|---|---|
| GE Healthcare | In 2024, GE Healthcare launched an AI-enabled 3D mammography system with enhanced image clarity and reduced scan times. In 2025, the company plans to expand its portable mammography solutions for remote screening. |
| Hologic, Inc. | In 2024, Hologic introduced its latest tomosynthesis system with improved lesion detection capabilities. In 2025, it aims to integrate AI-driven diagnostics and workflow optimization features. |
| Siemens Healthineers | Siemens developed a high-resolution mammography system with integrated biopsy guidance in 2024. In 2025, the company plans to advance its AI algorithms to support personalized breast cancer screening. |
| Fujifilm Holdings Corporation | Fujifilm launched a compact, mobile mammography unit targeting underserved areas in 2024. In 2025, the company will enhance its digital imaging software for improved diagnostic accuracy. |
Key Company Insights
GE Healthcare (22-26%)
GE Healthcare leads the market with innovative AI-enabled 3D mammography systems that improve diagnostic accuracy and patient comfort. Their investment in portable solutions expands access in remote areas.
Hologic, Inc. (18-22%)
Hologic focuses on advanced tomosynthesis technology and AI integration to enhance lesion detection and streamline clinical workflows, maintaining a strong presence in breast imaging.
Siemens Healthineers (15-19%)
Siemens offers high-resolution mammography systems with biopsy guidance features, supported by evolving AI tools to personalize breast cancer screening and diagnosis.
Fujifilm Holdings Corporation (10-13%)
Fujifilm specializes in mobile and compact mammography units designed for accessibility in underserved regions, coupled with continuous enhancements in digital imaging technologies.
Other Key Players (28-32% Combined)
The overall market size for the mammography market was USD 2,279.1 Million in 2025.
The market is expected to reach USD 5,700.1 Million in 2035.
Demand will be driven by increasing breast cancer prevalence, advancements in imaging technology, rising awareness about early detection, and growing healthcare infrastructure.
The top 5 contributing countries are USA, UK, Europe, Japan, and South Korea.
The Breast Tomosynthesis segment is expected to lead the market due to its enhanced imaging capabilities and widespread adoption.
Mammography Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
